Does Bad Medical News Reduce Preferences for Generic Drugs?
- 4 June 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Marketing
- Vol. 88 (1) , 160-178
Abstract
Policy makers and insurers promote the use of generic drugs because they can deliver large savings without sacrificing quality. But these efforts meet resistance from the public, who perceive generic drugs as inferior substitutes for brand name counterparts. Building on literature showing that negative emotions reduce risk-taking, the authors hypothesize that receiving bad medical news (i.e., negative information about one’s health) prompts patients to favor brand name over generic drugs as means to safeguard their health. The evidence exploits low-density lipoprotein cholesterol test results, where a discontinuity from clinical guidelines enables the authors to estimate the causal effect of bad medical news. Using data covering patients’ prescription drug choices across drug classes, the authors find that patients receiving bad medical news become 8% more likely to choose the brand name alternative. The findings are reinforced by a secondary analysis incorporating the similar context of hemoglobin A1c (blood sugar) testing. The authors also find that bad medical news reduces preferences for generics most strongly among drugs of direct clinical relevance for each test, but the effect also manifests among non–clinically relevant drugs.Keywords
Funding Information
- Hopkins Business of Health Initiative (Pilot Award)
This publication has 59 references indexed in Scilit:
- A Reduced-Form Approach to Behavioral Public FinanceAnnual Review of Economics, 2012
- Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message remindersAIDS, 2011
- A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of MalaysiaHealth Policy, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular DiseaseJAMA, 2008
- Impact of Alternative Interventions on Changes in Generic Dispensing RatesHealth Services Research, 2006
- Uncertainty and Learning in Pharmaceutical DemandEconometrica, 2005
- How Much Should We Trust Differences-In-Differences Estimates?The Quarterly Journal of Economics, 2004
- All Negative Moods Are Not Equal: Motivational Influences of Anxiety and Sadness on Decision MakingOrganizational Behavior and Human Decision Processes, 1999
- Pre and post analytical errors in lipid determinationIndian Journal of Clinical Biochemistry, 1996